Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11965000 Respiratory syncytial virus (RSV) vaccine

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 7, 2023
0
Date of Patent
April 23, 2024
0
Patent Application Number
18463276
0
Patent Citations
‌
US Patent 11369691 Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
0
‌
US Patent 11667910 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
‌
US Patent 11690910 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
0
‌
US Patent 11692002 RNA sequence adaptation
0
‌
US Patent 11697816 Artificial nucleic acid molecules
0
‌
US Patent 11760992 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
‌
US Patent 11761009 Artificial nucleic acid molecules for improved protein expression
0
‌
US Patent 11786590 Rotavirus vaccines
0
‌
US Patent 7001890 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
0
‌
US Patent 7208478 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
0
•••
Patent Inventor Names
Daniel Voss
0
Margit Schnee
0
Thomas Kramps
0
Benjamin Petsch
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11965000
0
Patent Primary Examiner
‌
Agnieszka Boesen
0

Find more entities like US Patent 11965000 Respiratory syncytial virus (RSV) vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo